Skip to main content
Premium Trial:

Request an Annual Quote

Almac Diagnostics Licenses Rosetta s Resolver System

NEW YORK, March 29 (GenomeWeb News) - Almac Diagnostics has licensed Rosetta Biosoftware's Resolver system to help it develop microarray-based approaches for diagnosing cancer and predicting therapeutic outcomes, the companies said today.

 

The company will also use the technology "in the provision of comprehensive gene expression analysis services" Almac offers to academic, biotech, and pharmaceutical customers.

 

The Rosetta Resolver system is developed and supported by Rosetta Biosoftware and is distributed exclusively by Agilent Technologies.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.